• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发可吸入型抗炎药物制剂,以潜在治疗烧伤患者烟雾吸入性损伤。

Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims.

机构信息

Advanced Drug Delivery Group, Faculty of Pharmacy (A15), University of Sydney, Sydney, NSW, 2006, Australia.

出版信息

Int J Pharm. 2010 Apr 15;389(1-2):41-52. doi: 10.1016/j.ijpharm.2010.01.014. Epub 2010 Jan 18.

DOI:10.1016/j.ijpharm.2010.01.014
PMID:20080165
Abstract

Injury arising from smoke inhalation is a significant mortality risk in severe burned patients. Inflammatory processes are major contributors to the development of respiratory insufficiency owing to pulmonary oedema, formation of airway fibrin clots and hypoxaemia. Anti-inflammatory and anti-coagulant drugs such as heparin and pentoxifylline are currently systemically administered for the treatment of smoke inhalation. Delivery of these drugs in the form of inhalable particles could be an effective manner to achieve rapid targeted action for acceleration of the treatment. The study developed and characterised a series of spray-dried heparin and pentoxifylline dry powder formulations suitable for inhalation administration. Drug particles were co-spray-dried with leucine in varying ratios. Particle size analysis confirmed all powders (except 2%, w/w, pentoxifylline with 1%, w/w, leucine in spray-drying feed solution) had particle size in the optimal range (< or =5 microm) for deep lung drug deposition. Leucine supplementation dramatically altered heparin surface topography while pentoxifylline formulations were a mixture of elongated needles interspersed with wrinkly particles. Addition of leucine improved fine particle fraction of heparin and pentoxifylline. The study indicated manufacture of inhalable heparin and pentoxifylline was feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.

摘要

吸入烟雾导致的损伤是严重烧伤患者的一个重要死亡风险。炎症过程是导致呼吸功能不全的主要原因,其表现为肺水肿、气道纤维蛋白血栓形成和低氧血症。肝素和己酮可可碱等抗炎和抗凝药物目前被系统地用于治疗烟雾吸入。以可吸入颗粒的形式给予这些药物可能是一种有效的方法,可以实现快速靶向作用,从而加速治疗。该研究开发并表征了一系列适合吸入给药的喷雾干燥肝素和己酮可可碱干粉制剂。药物颗粒与亮氨酸以不同的比例共喷雾干燥。粒径分析证实,所有粉末(除了喷雾干燥进料溶液中 2%(w/w)的己酮可可碱和 1%(w/w)的亮氨酸)的粒径都在适合深肺部药物沉积的最佳范围内(<或=5 微米)。亮氨酸的添加极大地改变了肝素的表面形貌,而己酮可可碱制剂则是长针和皱缩颗粒的混合物。亮氨酸的添加改善了肝素和己酮可可碱的微细颗粒分数。该研究表明,可吸入肝素和己酮可可碱的制造是可行的,并且可能是一种有吸引力的替代传统全身给药途径的给药方式。

相似文献

1
Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims.开发可吸入型抗炎药物制剂,以潜在治疗烧伤患者烟雾吸入性损伤。
Int J Pharm. 2010 Apr 15;389(1-2):41-52. doi: 10.1016/j.ijpharm.2010.01.014. Epub 2010 Jan 18.
2
Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.用于肺部给药的含纳米颗粒的喷雾干燥妥布霉素粉末的制备与表征
Int J Pharm. 2009 Jan 5;365(1-2):162-9. doi: 10.1016/j.ijpharm.2008.08.014. Epub 2008 Aug 22.
3
Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation.联合抗凝剂可改善烧伤和烟雾吸入后绵羊的急性肺损伤。
Clin Sci (Lond). 2008 Feb;114(4):321-9. doi: 10.1042/CS20070254.
4
Development of inhalable dry powder formulation of basic fibroblast growth factor.碱性成纤维细胞生长因子吸入干粉制剂的研制。
Int J Pharm. 2010 Jan 29;385(1-2):66-72. doi: 10.1016/j.ijpharm.2009.10.029. Epub 2009 Oct 21.
5
Characterization of a new inhalable thymopentin formulation.一种新型可吸入胸腺五肽制剂的特性研究
Int J Pharm. 2009 Jun 22;375(1-2):1-7. doi: 10.1016/j.ijpharm.2009.03.020. Epub 2009 Mar 26.
6
Sustained delivery by leucine-modified chitosan spray-dried respirable powders.通过亮氨酸修饰壳聚糖喷雾干燥可吸入粉末实现持续释放。
Int J Pharm. 2009 May 8;372(1-2):97-104. doi: 10.1016/j.ijpharm.2009.01.017. Epub 2009 Jan 24.
7
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.用于测定雾化粉末制剂粒度的激光衍射方法的开发。
Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16.
8
Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.喷雾干燥法制备的吸入用胰岛素干粉的物理特性和气雾化性能
J Pharm Pharmacol. 2007 Jul;59(7):927-34. doi: 10.1211/jpp.59.7.0003.
9
Formulation strategy and use of excipients in pulmonary drug delivery.肺部给药的制剂策略和辅料应用。
Int J Pharm. 2010 Jun 15;392(1-2):1-19. doi: 10.1016/j.ijpharm.2010.03.017. Epub 2010 Mar 17.
10
Development and testing of particulate formulations for the nasal delivery of antibodies.用于抗体鼻腔给药的颗粒制剂的研发与测试。
J Control Release. 2009 Apr 17;135(2):127-35. doi: 10.1016/j.jconrel.2008.11.009. Epub 2008 Nov 24.

引用本文的文献

1
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities.新冠疫情时代的药物重新利用:来自显示制药特性的案例研究的见解
Pharmaceutics. 2021 Feb 25;13(3):302. doi: 10.3390/pharmaceutics13030302.
2
Lung [(18)F]fluorodeoxyglucose uptake and ventilation-perfusion mismatch in the early stage of experimental acute smoke inhalation.实验性急性烟雾吸入早期肺部 [(18)F]氟脱氧葡萄糖摄取和通气-灌注不匹配。
Anesthesiology. 2014 Mar;120(3):683-93. doi: 10.1097/01.anes.0000435742.04859.e8.